DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20205120

A study of effect of a single dose of second generation antihistaminics on cognitive and psychomotor function in healthy human volunteers

Kirti Saxena, Sachendra K. Shrivastva, Chaitali Mehta

Abstract


Background: Objective of the study was to assess whether second generation antihistaminic alter psychomotor and cognitive function in comparison with promethazine (marked sedation; altered psychomotor and cognitive impairment).

Methods: It was a single blind prospective study. Seventy five healthy human volunteers were registered, divided in five groups. These groups have received placebo, promethazine 25 mg, cetirizine 10 mg, fexofenadine 120 mg and loratadine 10 mg. Cognitive and psychomotor functions were assessed pretreatment and 60 minutes after single dose of drug(post treatment)by using a battery of standard tests (e.g. PST-Perceptual speed test, BVRT-Benton visual retention test,SSS- Stanford Sleepiness Scale, FTT-Finger tapping test etc.). The data were analyzed by student’s t-test and ANOVA test.

Results: No significant effect was observed in any test parameter with placebo and fexofenadine. Significant difference with promethazine in PST, BVRT, SSS and cetirizine in DSST, FTT and loratadine in DSST were observed. Significant difference was observed in DSST between the placebo and promethazine, in SSS between promethazine and all other drugs. In FTT and BVRT significant difference between the groups were observed.

Conclusions: Significant sedation and altered cognitive and psychomotor function were observed with promethazine. Cetirizine and loratadine do not cause sedation but both affect psychomotor functions. No significant effect was produced by fexofenadine. Thus, fexofenadine can safely be used in persons involved in activity where alertness is required while cetirizine and loratadine should be avoided.


Keywords


Antihistaminic, Cognitive function, Psychomotor function, Sedation

Full Text:

PDF

References


Brunton LL, editor. Goodman and Gillman's The Phramacological Basis of Therapeutics. McGraw Hill Education.12th edition. 2017.

Okamura N, Yanai K, Higuchi M, Sakai J, Iwata R, Ido T, et al. Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine. Br J Pharmacol. 2000;129(1):115-23.

Tashiro M, Sakurada Y, Iwabuchi K, Mochizuki H, Kato M, Aoki M, et al. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, andbrain histamine H1-receptor occupancy using C-11 doxepin positron emission tomography. J Clin Pharmacol. 2004;44:890-900.

Br A. Sedation and performance issues in the treatment of allergic conditions. Arch Intern Med. 1997;157(5):494-500.

Mann RD, Pearce GL, Dunn N, Shakir S. Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice. Brit Med J. 2000;320(7243):1184-6.

Tashiro M, Kato M, Miyake M, Watanuki S, Funaki Y, Ishikawa Y, et al. Dose dependency of brain histamine H1 receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C] doxepin. Hum Psychopharmacol Clin Exp. 2009;24:540-8.

Valk PJ, Simons M. Effects of loratadine/montelukast on vigilance and alertness task performance in a simulated cabin environment. Adv Ther. 2009;26(1):89-98.

Ozdemir PG, Karadag AS, Selvi Y, Boysan M, Bilgili SG, Aydin A, et al. Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety. Int J Psychiatry Clin Pract. 2014;18(3):161-8.

Soper JW, Chaturvedi AK, Canfield DV. Prevalence of chlorpheniramine in aviation accident pilot fatalities, 1991–1996. Oklahoma: Civil Aeromedical Institute, Federal Aviation Administration, Oklahoma; 1999. Report No.: ADA372538.

Wechsler adult intelligence scale revised. Available at https://link.springer.com/chapter/10.1007/978-1-4757-3224-5_6. Accessed on 12 June 2020.

Matarazzo JD, Herman DO. Base rate data for the WAIS-R: test-retest stability and VIQ-PIQ differences. J Clin Neuropsychol. 1984;6:351-66.

Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy. 2002;32(1):133-9.

David VK, Badyal DK, Varghese A, Alexander E. Comparative effect of newer antihistamines on psychomotor functions in Indian population. J K Science. 2010;12(1):15-8.

Jáuregui I, Mullol J, Bartra J, Cuvillo D, Dávila I, Montoro J, et al. H1 antihistamines: psychomotor performance and driving. J Investig Allergol Clin Immunol. 2006;16(1):37-44.

Kamei H, Isaji A, Noda Y, Ishikawa K, Senzaki K, Yamada K, et al. Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers. Arch Dermatol Res. 2012;304(4):263-72.

Church MK, Maurer M, Simons FE, Jensen C, Cauwenberge P, Bousquet J, et al. Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy. 2010;65(4):459-66.

Sen A, Akin A, Craft KJ, Canfield DV, Chaturvedi AK. First-generation H1 antihistamines found in pilot fatalities of civil aviation accidents, 1990-2005. Aviat Space Environ Med. 2007;78(5):514-22.

Gengo FM, Gabos C, Mechler L. Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator. Ann Allergy. 1990;64:520-6.

Gupta S, Kapoor B, Gillani Z, Kapoor V, Gupta BM. Effects of fexofenadine, cetirizine and diphenhydramine on psychomotor performance in adult healthy volunteer. J K Science. 2004;6(4):201-5.

Simons FE, Fraser TG, Simons KJ, Reggin JD. Individual differences in central nervous system response to antihistamines (H1-receptor antagonists). Ann Allergy Asthma Immunol. 1995;75(6):507-14.

Bender BG, Berning S, Dudden R, Milgrom H, Tran ZV. Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis. J Allergy Clin Immunol. 2003;111(4):770-6.

Vermeeren A, O’Hanlon JF. Fexofenadine’s effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol. 1998;101:306-11.

Valk PJ, Simons M. Effects of loratadine/montelukast on vigilance and alertness task performance in a simulated cabin environment. Adv Ther. 2009;26(1):89-98.